Arch Therapeutics Inc (ARTH)

[Regis999]

Interesting comment on ARTH ARCH from seeking alpha:

"Several observations: ARTH cannot fully publish data and then get an article in a peer-reviewed publication. Strategic partners look at peer-reviewed publications as being the litmus test of credibility.

The ARTH advisory group is not going to risk their scientific credibility by hyping the results of this initial trial so I place great emphasis on what they have to say.

Anyone who doesn't think a 41% reduction in bleeding is significant is a moron. ANYTIME you can reduce bleeding time, you do so. Period. Ask any surgeon.

Finally, any company in this space that shows even modest results is eventually purchased. I have no doubt that ARTH will find a strategic partner or get purchased and at multiples significantly higher than the stock price today."

Elevator Summary of ARCH http://www.archtherapeutics.blogspot.com/